Increased expression of inhibitory immune checkpoint molecules such as programmed cell death ligand 1 (PDL-1) by myeloma and bone marrow microenvironment cells together with an increased expression of PDCD1 and CTLA4 on tumor infiltrating T cells contribute to maintaining the immunosuppressive state in MM (29, 30). Here, CTLA4 is linked to Miyoshi myopathy.